Examkin

Soru

Zorluk: ZorBipolar and Related Disorders

Match each clinical scenario describing a patient with a bipolar spectrum disorder to the most appropriate next step in pharmacological management.

  • A 24-year-old woman presents with acute bipolar depression. She has a documented history of Stevens-Johnson syndrome following a trial of an unknown antiepileptic drug during childhood.Initiate lurasidone
  • A 28-year-old woman at 9 weeks gestation is admitted for acute, severe mania with psychotic features, marked agitation, and total lack of sleep.Initiate haloperidol
  • A 60-year-old man requires pharmacological intervention for an acute manic episode. He has a history of decompensated cirrhosis due to chronic alcohol use, but his baseline renal function is entirely normal.Initiate lithium
  • A 45-year-old man requires initiation of maintenance pharmacotherapy for bipolar I disorder. He has chronic kidney disease stage 4 (eGFR 25 mL/min/1.73 m2) secondary to hypertensive nephrosclerosis.Initiate valproate

Cevap

Match the scenarios based on absolute contraindications: use lurasidone for the patient with prior Stevens-Johnson syndrome, haloperidol for the pregnant patient in the first trimester, lithium for the patient with severe cirrhosis, and valproate for the patient with severe chronic kidney disease.
Each clinical scenario involves a specific contraindication that eliminates a commonly used first-line bipolar medication, necessitating the selection of an alternative agent with a safe pharmacokinetic or adverse effect profile matched to that patient's systemic comorbidity.

Adım Adım Çözüm

1
Analyze the specific phase of bipolar disorder for each patient
Identified presentations of acute depression, acute mania, and the need for maintenance therapy.
Different phases dictate whether an antidepressant (like lurasidone), antimanic (like haloperidol), or standard mood stabilizer is indicated.
2
Evaluate the comorbid medical conditions and medication history
Identified prior Stevens-Johnson syndrome, first-trimester pregnancy, decompensated cirrhosis, and severe chronic kidney disease.
Medical comorbidities represent the primary driver for eliminating standard therapies that might otherwise be considered first-line.
3
Eliminate strictly contraindicated medications for each patient
Avoid lamotrigine in the patient with prior SJS. Avoid valproate, carbamazepine, and lithium in the pregnant patient. Avoid valproate in the cirrhotic patient. Avoid lithium in the chronic kidney disease patient.
Failure to recognize these contraindications can result in catastrophic adverse effects such as hepatotoxicity, nephrotoxicity, severe cutaneous reactions, and teratogenicity.
4
Select the optimal remaining pharmacological agent
Lurasidone (SJS patient), haloperidol (pregnant patient), lithium (cirrhosis patient), and valproate (CKD patient) are properly selected.
These specific agents effectively treat the corresponding mood phase while bypassing the patients' specific metabolic vulnerabilities and contraindications.

Anahtar Kavram

Pharmacotherapy selection in bipolar disorder requires careful consideration of the phase of illness and the patient's medical comorbidities, particularly baseline renal function, hepatic function, pregnancy status, and history of severe adverse drug reactions.
Bu soruyu puanla

Konular

Bipolar and Related Disorders

Bu konudan daha fazla soru